Literature DB >> 29484690

Lymphomas and thyroid: Bridging the gap.

Salvatrice Mancuso1, Melania Carlisi1, Mariasanta Napolitano1, Sergio Siragusa1.   

Abstract

The thyroid gland is often involved in the development of neoplastic diseases, including lymphoproliferative disorders. The aim of this paper is to provide a comprehensive overview of the multiple interactions between lymphoma and thyroid. Through an extensive research among the literature, the relationship between lymphomas and thyroid can be established at various levels, and the possible interconnections are here summarized in 5 points: (1) the greater risk of lymphoma development in some thyroid diseases; (2) the primary thyroid lymphoma, with focus on issues related to the diagnosis, differential diagnosis, and treatment; (3) the incidence of thyroid involvement in primitive nodal lymphomas or in extranodal lymphomas of the other sites; (4) thyroid changes after treatment of lymphoma, in relation to the effects of radiation therapy and immuno-chemotherapy; (5) the incidental findings of thyroid changes, on imaging, in patients with lymphoma, without a direct involvement of the gland in malignant disease. In conclusion, issues that until now have been dealt with separately will therefore be analyzed in a unique paper, allowing a global view of the topic and emphasizing the need of a multidisciplinary approach. Future learning areas in this topic mainly relate to rapidly increasing the knowledge of imaging studies together with expanding the armamentarium of novel biological and targeting agents in lymphoma patients.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Hashimoto's thyroiditis; primary thyroid lymphoma; radio and immuno-chemotherapy; secondary thyroid lymphoma; thyroid incidentaloma

Year:  2018        PMID: 29484690     DOI: 10.1002/hon.2504

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN: 0278-0232            Impact factor:   5.271


  6 in total

1.  Thyroid dysfunction induced by nivolumab: searching for disease patterns and outcomes.

Authors:  Inmaculada Peiró; Ramón Palmero; Pedro Iglesias; Juan José Díez; Andreu Simó-Servat; Juan Antonio Marín; Laura Jiménez; Eva Domingo-Domenech; Nuria Mancho-Fora; Ernest Nadal; Carlos Villabona
Journal:  Endocrine       Date:  2019-02-25       Impact factor: 3.633

2.  Secondary thyroid malignancy from metastatic colon lymphoma.

Authors:  Cristian Marco-Alacid; Mario López-Merseguer; Carlos Sánchez-Juan
Journal:  BMJ Case Rep       Date:  2019-03-16

3.  The Risk of Developing Lymphoma among Autoimmune Thyroid Disorder Patients: A Cross-Section Study.

Authors:  Mubarak Al-Mansour; Alaa Fawzi Maglan; Meral Khalid Altayeb; Laila Ali Faraj; Esraa Aman Felimban; Syed Sameer Aga; Mohammad Anwar Khan
Journal:  Dis Markers       Date:  2022-06-03       Impact factor: 3.464

4.  Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.

Authors:  Sara J Schonfeld; Lindsay M Morton; Amy Berrington de González; Rochelle E Curtis; Cari M Kitahara
Journal:  Cancer Epidemiol       Date:  2019-12-26       Impact factor: 2.984

Review 5.  Vitiligo and chronic autoimmune thyroiditis.

Authors:  Florica Sandru; Mara Carsote; Simona Elena Albu; Mihai Cristian Dumitrascu; Ana Valea
Journal:  J Med Life       Date:  2021 Mar-Apr

6.  Differential diagnosis of non-diffuse primary thyroid lymphoma and papillary thyroid carcinoma by ultrasound combined with computed tomography.

Authors:  Chanjuan Peng; Dan Yi; Ying Zhou; Jincao Yao; Bo Chen; Chen Yang; Dong Xu
Journal:  BMC Cancer       Date:  2022-08-31       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.